Comparison of pharmacokinetics of omega-3 fatty acid supplements in monoacylglycerol or ethyl ester in humans: a randomized controlled trial
Authors:
Open Access
- 3 October 2020
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Nutrition
- Vol. 75 (4) , 680-688
Abstract
Background: A diet low in omega-3 fatty acids (n-3 FA) results in low plasma concentrations of docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), the two main long chain n-3 FA. n-3 FA supplements on the market are esterified in triglycerides (TG) or ethyl ester (EE); the latter is absorbed less than other esterification forms. The objective of this study was to test and compare the pharmacokinetics of n-3 FA esterified in monoacylglycerides (MAG), a predigested form, with the EE form. Methods: This study was a randomized, double-blind, crossover, controlled, clinical trial. Ten men and ten women between 18 and 60 years old were recruited. Participants received a single oral dose of 3 g of n-3 FA esterified in EE or MAG. Eleven blood samples were collected over 24 h post-dose. Plasma total lipids were extracted, methylated, and analyzed using gas chromatography. Results: After receiving the MAG form, plasma EPA and DHA peaked at a concentration 3 and 2.5 times higher, respectively, than with the EE form. When provided in MAG form, n-3 FA plasma concentration during the absorption phase was on average 3–5 times higher than in EE form. When n-3 FAs were provided esterified in MAG, their concentration 24 h post-dose was higher than in EE. Males had a lower n-3 FA plasma concentration than females when n-3 FAs were provided in EE but there was no sexe difference when provided in MAG. Conclusions: Plasma concentration of DHA and EPA was higher when provided in MAG than EE form.Keywords
Funding Information
- Neptune Wellness Solution
This publication has 38 references indexed in Scilit:
- Steady-state bioavailability of prescription omega-3 on a low-fat diet is significantly improved with a free fatty acid formulation compared with an ethyl ester formulation: the ECLIPSE II studyVascular Health and Risk Management, 2013
- Changes in rat n-3 and n-6 fatty acid composition during pregnancy are associated with progesterone concentrations and hepatic FADS2 expressionProstaglandins, Leukotrienes and Essential Fatty Acids, 2012
- Plasma incorporation, apparent retroconversion and β-oxidation of 13C-docosahexaenoic acid in the elderlyNutrition & Metabolism, 2011
- Incorporation of EPA and DHA into plasma phospholipids in response to different omega-3 fatty acid formulations - a comparative bioavailability study of fish oil vs. krill oilLipids in Health and Disease, 2011
- Neuroprotective and Ameliorative Actions of Polyunsaturated Fatty Acids Against Neuronal Diseases: Beneficial Effect of Docosahexaenoic Acid on Cognitive Decline in Alzheimer’s DiseaseJournal of Pharmacological Sciences, 2011
- Plasman-3 fatty acid response to ann-3 fatty acid supplement is modulated by apoE ɛ4 but not by the common PPAR-α L162V polymorphism in menBritish Journal of Nutrition, 2009
- Cardiovascular benefits of omega-3 fatty acidsCardiovascular Research, 2007
- Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular DiseaseCirculation, 2002
- Lymphatic Absorption of Docosahexaenoic Acid Given as Monoglyceride, Diglyceride, Triglyceride, and Ethyl Ester in Rats.Journal of Nutritional Science and Vitaminology, 2002
- Human absorption of fish oil fatty acids as triacylglycerols, free acids, or ethyl estersBiochemical and Biophysical Research Communications, 1988